Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • MJFF Research Grant, 2010
    Promoting Widespread Data Sharing Among Scientists

    Objective/Rationale
    When scientists carry out experiments and observations, they typically have very specific questions.  It is frequently the case that data collection is relevant to issues and...

  • Target Validation, 2010
    Pharmacodynamics and Neuroprotective Effects of Pegylated G-CSF

    Promising Outcomes of Original Grant:
    We have discovered that a specific protein, granulocyte-colony stimulating factor (G-CSF), is effective in reducing nerve cell death and thereby disease...

  • MJFF Research Grant, 2010
    Optimization of Optical Coherence Tomography as a Biomarker for Parkinson's Disease

    Objective/Rationale:
    Determine the thickness of the neural part of the eye, the retina in patients suffering from Parkinson Disease and in healthy, age matched subjects.

    Project Description:
    Patients...

  • MJFF Research Grant, 2010
    Making PSG Databases Available to Researchers

    Objective/Rationale
    Information from clinical trials is not easily available to most researchers, especially if the trials are sponsored by industry. Making information from clinical trials more...

  • Rapid Response Innovation Awards, 2010
    Increasing Endogenous Neurogenesis Using Neurosteroids: A Novel Therapeutic Strategy to Treat Parkinson's Disease

    Objective/Rationale
    We will test a locally produced brain chemical that increases the generation of new neurons to replace the damaged neurons in Parkinson disease (PD). The production of this...

  • Neurotrophic Factor Therapies for Parkinson's Disease, 2010
    CERE-120 Long-Term Subject Follow-Up

    Outcomes of Original Grant:
    Neurotrophic factors including neurturin (NTN) have been shown to effectively augment the function and prevent the death of dopaminergic nigrostriatal neurons in animal...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.